Current status of global harmonization of GMP standards in PIC/S and future prospects of effective GMP inspection by PMDA
The author has been involved in the management of PIC/S since January 2022 as Executive Bureau Member. The current status of global harmonization of GMP standards, the challenges facing PIC/S and the significance of participating in PIC/S activities are described in this review article with the auth...
Saved in:
Published in | PDA Journal of GMP and Validation in Japan Vol. 24; no. 2; pp. 45 - 56 |
---|---|
Main Author | |
Format | Journal Article |
Language | Japanese |
Published |
Parenteral Drug Association Japan Chapter
2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The author has been involved in the management of PIC/S since January 2022 as Executive Bureau Member. The current status of global harmonization of GMP standards, the challenges facing PIC/S and the significance of participating in PIC/S activities are described in this review article with the author's personal views. PMDA, Ministry of Health, Labour and Welfare (MHLW) and 47 prefectures of Japan became PIC/S' Participating Authority in 2014. To ensure the quality of medicines distributed on the global market, PIC/S including the PMDA should try to develop more effective GMP regulations. |
---|---|
ISSN: | 1344-4891 1881-1728 |
DOI: | 10.11347/pda.24.45 |